Related Experiment Video
Updated: May 16, 2026

Bioreactor Assembly for Continuous Culture of Complex Fecal Communities
Published on: April 25, 2025
Bioreactors get personal
Robert P T Somerville1, Mark E Dudley
1Surgery Branch; National Cancer Institute; National Institutes of Health; Bethesda, MD USA.
Abstract:
Adoptive cell transfer immunotherapy against melanoma is highly effective. However, this therapy has seen limited dissemination, mainly due to the complexity and costs of cell expansion protocols. Two bioreactors have recently been described that simplify and streamline the production of individualized cell therapies. Such bioreactors might increase the number of patients that get access to this promising therapeutic modality.
Related Concept Videos
Bioreactor Design and Operational System
Bioreactor Controls-II
Bioreactor Controls-III
Bioreactor Controls-I
Designing Growth Media for Bioreactors
Upstream Processing

